New light therapy targets hard-to-treat blood cancer
NCT ID NCT07075328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new treatment called OJP-001 for people with adult T-cell leukemia/lymphoma (ATLL) that has come back after prior therapy. The treatment uses a light-sensitive drug and a machine to treat the blood outside the body, aiming to kill cancer cells. The study will check safety, find the best dose, and see how well it works in up to 49 participants aged 20 to 85.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Imamura general hospital
RECRUITINGKagoshima, Kagoshima-ken, Japan
-
Nagasaki University Hospital
RECRUITINGNagasaki, Nagasaki, Japan
-
National Kyushu Cancer Center
RECRUITINGFukuoka, Fukuoka, Japan
-
Sapporo Hokuyu Hospital
RECRUITINGSapporo, Hokkaido, Japan
-
University of Miyazaki Hospital
RECRUITINGMiyazaki, Miyazaki, Japan